- Home
- PPBT vs VEEE Comparison
PPBT vs VEEE Comparison
Compare PPBT & VEEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PPBT
- VEEE
- Stock Information
- Founded
- PPBT 2010
- VEEE 1994
- Country
- PPBT Israel
- VEEE United States
- Employees
- PPBT N/A
- VEEE N/A
- Industry
- PPBT Biotechnology: Pharmaceutical Preparations
- VEEE Marine Transportation
- Sector
- PPBT Health Care
- VEEE Industrials
- Exchange
- PPBT Nasdaq
- VEEE Nasdaq
- Market Cap
- PPBT 6.3M
- VEEE 6.4M
- IPO Year
- PPBT N/A
- VEEE 2021
- Fundamental
- Price
- PPBT $2.62
- VEEE $2.46
- Analyst Decision
- PPBT Strong Buy
- VEEE
- Analyst Count
- PPBT 1
- VEEE 0
- Target Price
- PPBT $33.00
- VEEE N/A
- AVG Volume (30 Days)
- PPBT 30.8K
- VEEE 1.1M
- Earning Date
- PPBT 05-21-2025
- VEEE 05-08-2025
- Dividend Yield
- PPBT N/A
- VEEE N/A
- EPS Growth
- PPBT N/A
- VEEE N/A
- EPS
- PPBT N/A
- VEEE N/A
- Revenue
- PPBT N/A
- VEEE $12,724,465.00
- Revenue This Year
- PPBT N/A
- VEEE N/A
- Revenue Next Year
- PPBT N/A
- VEEE N/A
- P/E Ratio
- PPBT N/A
- VEEE N/A
- Revenue Growth
- PPBT N/A
- VEEE N/A
- 52 Week Low
- PPBT $2.00
- VEEE $2.05
- 52 Week High
- PPBT $13.95
- VEEE $9.30
- Technical
- Relative Strength Index (RSI)
- PPBT 56.64
- VEEE 48.05
- Support Level
- PPBT $2.46
- VEEE $2.13
- Resistance Level
- PPBT $2.80
- VEEE $2.35
- Average True Range (ATR)
- PPBT 0.20
- VEEE 0.17
- MACD
- PPBT 0.04
- VEEE 0.00
- Stochastic Oscillator
- PPBT 66.96
- VEEE 44.59
About PPBT Purple Biotech Ltd.
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219: A dual inhibitor, small molecule that simultaneously targets Insulin Receptor Substrate 1 and 2 (IRS1/2) and Signal Transducer and Activator of Transcription (STAT3), two survival signal transduction pathways driving the development of cancer drug resistance. and CM24: is a humanized monoclonal antibody designed to block the interactions of Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 (CEACAM1), a glycoprotein that plays a key role in immune regulation, cell adhesion, and tumor progression, CAPTN3.
About VEEE Twin Vee PowerCats Co.
Twin Vee PowerCats Co is a designer, manufacturer, and marketer of recreational and commercial power catamaran boats to use for fishing, diving and water skiing and commercial activities including transportation, eco-tours, fishing, and diving expeditions. Its revenue is derived from the sale of boats, motors, and trailers to its independent dealers. It has organized its business into three operating segments: The gas-powered boat segment, which manufactures and distributes gas-powered boats; The electric-powered boat segment, which is developing fully electric boats, through its controlling interest subsidiary, and its franchise segment, which is developing a standard product offering and will be selling franchises across the United States through its wholly-owned subsidiary.